Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 176

1.

Attention-deficit/hyperactivity disorder in elite athletes: a narrative review.

Han DH, McDuff D, Thompson D, Hitchcock ME, Reardon CL, Hainline B.

Br J Sports Med. 2019 Jun;53(12):741-745. doi: 10.1136/bjsports-2019-100713. Epub 2019 May 16. Review.

PMID:
31097459
2.

The role of the circadian system in the etiology and pathophysiology of ADHD: time to redefine ADHD?

Bijlenga D, Vollebregt MA, Kooij JJS, Arns M.

Atten Defic Hyperact Disord. 2019 Mar;11(1):5-19. doi: 10.1007/s12402-018-0271-z. Epub 2019 Mar 29. Review.

PMID:
30927228
3.

Social Functioning in Youth with Attention-Deficit/Hyperactivity Disorder and Sluggish Cognitive Tempo.

Ferretti NM, King SL, Hilton DC, Rondon AT, Jarrett MA.

Yale J Biol Med. 2019 Mar 25;92(1):29-35. eCollection 2019 Mar. Review.

4.

Brain alterations in children/adolescents with ADHD revisited: A neuroimaging meta-analysis of 96 structural and functional studies.

Samea F, Soluki S, Nejati V, Zarei M, Cortese S, Eickhoff SB, Tahmasian M, Eickhoff CR.

Neurosci Biobehav Rev. 2019 May;100:1-8. doi: 10.1016/j.neubiorev.2019.02.011. Epub 2019 Feb 18. Review.

PMID:
30790635
5.

Genetic risk factors and gene-environment interactions in adult and childhood attention-deficit/hyperactivity disorder.

Palladino VS, McNeill R, Reif A, Kittel-Schneider S.

Psychiatr Genet. 2019 Jun;29(3):63-78. doi: 10.1097/YPG.0000000000000220. Review.

PMID:
30741787
6.

Update the Multimodal Treatment of ADHD (MTA): twenty years of lessons.

Martínez-Núñez B, Quintero J.

Actas Esp Psiquiatr. 2019 Jan;47(1):16-22. Epub 2019 Jan 1. Review.

7.

White noise as a possible therapeutic option for children with ADHD.

Pickens TA, Khan SP, Berlau DJ.

Complement Ther Med. 2019 Feb;42:151-155. doi: 10.1016/j.ctim.2018.11.012. Epub 2018 Nov 13. Review.

PMID:
30670235
8.

Pharmacological treatment of attention-deficit/hyperactivity disorder in children and adolescents with epilepsy.

Auvin S.

Rev Neurol (Paris). 2019 Mar;175(3):141-143. doi: 10.1016/j.neurol.2018.11.003. Epub 2019 Jan 18. Review.

PMID:
30665686
9.

Risk of Attention Deficit/Hyperactivity Disorder (ADHD) and Other Psychiatric Disorders in Siblings of ADHD Probands.

Hidalgo-López C, Gómez-Álzate AM, García-Valencia J, Palacio-Ortiz JD.

Rev Colomb Psiquiatr. 2019 Jan - Mar;48(1):44-49. doi: 10.1016/j.rcp.2017.06.002. Epub 2017 Jul 26. Review. English, Spanish.

PMID:
30651172
10.

Stimulant Formulations for the Treatment of Attention-Deficit/Hyperactivity Disorder.

Gautam M, Prabhakar D.

Prim Care Companion CNS Disord. 2018 Dec 27;20(6). pii: 18r02345. doi: 10.4088/PCC.18r02345. Review.

11.

Natural Compounds for the Management of Parkinson's Disease and Attention-Deficit/Hyperactivity Disorder.

Corona JC.

Biomed Res Int. 2018 Nov 22;2018:4067597. doi: 10.1155/2018/4067597. eCollection 2018. Review.

13.

Pharmacotherapeutic strategies for the treatment of attention-deficit hyperactivity (ADHD) disorder with comorbid substance-use disorder (SUD).

Perugi G, Pallucchini A, Rizzato S, De Rossi P, Sani G, Maremmani AG, Pinzone V, Maremmani I.

Expert Opin Pharmacother. 2019 Feb;20(3):343-355. doi: 10.1080/14656566.2018.1551878. Epub 2018 Dec 4. Review.

PMID:
30513231
14.

Diagnosis and treatment of ADHD in children vs adults: What nurses should know.

Leahy LG.

Arch Psychiatr Nurs. 2018 Dec;32(6):890-895. doi: 10.1016/j.apnu.2018.06.013. Epub 2018 Jun 4. Review.

PMID:
30454634
15.

Attention-deficit/hyperactivity disorder: clinical pharmacology and dental implications.

Mousavian MM, Saraghi M, Hersh EV.

Gen Dent. 2018 Nov-Dec;66(6):9-11. Review. No abstract available.

PMID:
30444700
16.

Cross-species models of attention-deficit/hyperactivity disorder and autism spectrum disorder: lessons from CNTNAP2, ADGRL3, and PARK2.

Dalla Vecchia E, Mortimer N, Palladino VS, Kittel-Schneider S, Lesch KP, Reif A, Schenck A, Norton WHJ.

Psychiatr Genet. 2019 Feb;29(1):1-17. doi: 10.1097/YPG.0000000000000211. Review.

PMID:
30376466
17.
18.

Light up ADHD: II. Neuropharmacological effects measured by near infrared spectroscopy: is there a biomarker?

Grazioli S, Mauri M, Crippa A, Maggioni E, Molteni M, Brambilla P, Nobile M.

J Affect Disord. 2019 Feb 1;244:100-106. doi: 10.1016/j.jad.2018.10.100. Epub 2018 Oct 9. Review.

PMID:
30332620
19.

Structural and functional neuroimaging in attention-deficit/hyperactivity disorder.

Albajara Sáenz A, Villemonteix T, Massat I.

Dev Med Child Neurol. 2019 Apr;61(4):399-405. doi: 10.1111/dmcn.14050. Epub 2018 Oct 1. Review.

PMID:
30276811
20.

Screen media use and ADHD-related behaviors: Four decades of research.

Beyens I, Valkenburg PM, Piotrowski JT.

Proc Natl Acad Sci U S A. 2018 Oct 2;115(40):9875-9881. doi: 10.1073/pnas.1611611114. Review.

Supplemental Content

Loading ...
Support Center